The Pharmacist’s Role in Combination Cancer Treatments

Voice

Description

Since the first checkpoint inhibitor was approved in 2011, we have made tremendous leaps in immunotherapy in a short span of 10 years. Now we see immunotherapy combined with a variety of options, including chemotherapy or other oral and IV targeted therapy.

View Article @ voice.ons.org